Early Onset Cannabis Use and Progression to other Drug Use in a Sample of Dutch Twins
- 705 Downloads
One possible explanation of the commonly reported associations between early onset cannabis use and elevated risks of other illicit drug use is that early onset cannabis use increases access and availability to other drugs. It was this argument that in part motivated policy changes in the Netherlands that led to the de facto legalization of cannabis there. This study examines, using a co-twin control design, whether previously observed associations between early onset cannabis use and elevated lifetime rates of other illicit drug use would also be observed in a sample of 219 same sex Dutch twin pairs discordant for cannabis use before age 18. After adjustment for covariates, rates of lifetime party drug use (OR=7.4, 95% CI=2.3–23.4), hard drug use (OR=16.5, 95% CI=2.4–111.3), but not regular cannabis use (OR=1.3, 95% CI=0.3–5.1) were significantly elevated in individuals who reported early onset cannabis use, relative to their co-twin who had not used cannabis by age 18. The elevated odds of subsequent illicit drug use in early cannabis users relative to their non early using co-twins suggests that this association could not be explained by common familial risk factors, either genetic or environmental, for which our co-twin methodology provided rigorous control.
KeywordsCannabis other illicit drug use twins, gateway theory The Netherlands
This work was supported by the Netherlands Organization for Scientific Research (NWO 985-10-002 and NWO 575-25-006) and by grant DA18660 from the NIH.
- Achenbach, T. M. (1997). Manual for the Young Adult Self Report and Young Adult Behavior Checklist, Burlington, VT: University of Vermont Department of Psychiatry.Google Scholar
- Australian Institute of Health and Welfare. (1999). 1998 National Drug Strategy Household Survey: First Results, Canberra: Australian Institute of Health and Welfare.Google Scholar
- Collins, L. M. (2002). Using latent transition analysis to examine the gateway hypothesis. In D. B. Kandel (ed.), Stages and pathways of drug involvement: Examining the gateway hypothesis, Cambridge, UK: Cambridge University Press, pp. 254–269.Google Scholar
- Kandel, D. B., and Faust, R. (1975). Sequences and stages in patterns of adolescent drug use. Arch. Gen. Psych. 32:923–932.Google Scholar
- Kandel, D. B., and Yamaguchi, K. (2002). Stages of drug involvement in the US population. In D.B. Kandel (ed.), Stages and pathways of drug involvement: Examining the gateway hypothesis, Cambridge, UK: Cambridge University Press, pp. 65–81.Google Scholar
- Kleiman, M. (1992). Against Excess: Drug Policy for Results. New York: Basic Books.Google Scholar
- MacCoun, R. (1998). In what sense (if any) is marijuana a gateway drug? FAS Drug Policy Anal. Bull. Issue 4(http://www.fas.org/drugs/issue4.htm#gateway)
- SAS Institute Inc. (1996). SAS/ STAT Software: Changes and Enhancements for Release 6.12. Cary, NC: SAS Institute Inc.Google Scholar
- StataCorp. (1999). Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation.Google Scholar
- Verhulst, F. C., Ende van de, J., Koot, H. M., and Handleiding, voor de. (1997). Youth Self-Report. Rotterdam: Afdeling Kinder- en Jeugdpsychiatrie, Sophia Kinderziekenhuis/Academisch Ziekenhuis Rotterdam/Erasmus Universiteit Rotterdam.Google Scholar
- Yamaguchi, K., and Kandel, D. B. (1984). Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. Am. J. Pub. Hlth. 74:673–681.Google Scholar